Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis Compared to Standard Care --- a Pragmatic Observational Study
Latest Information Update: 28 Nov 2022
At a glance
- Drugs Secukinumab (Primary) ; Acitretin; Ciclosporin; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
Most Recent Events
- 23 Nov 2022 Planned End Date changed from 1 Dec 2026 to 1 Dec 2027.
- 23 Nov 2022 Planned primary completion date changed from 1 Dec 2026 to 1 Dec 2027.
- 22 Nov 2022 Planned initiation date changed from 1 Jan 2022 to 1 Jan 2024.